That's right. He's saying they've expended all the CFT funding...

That's right. He's saying they've expended all the CFT funding accrued up to the end of 2023. They would still have CFT funding accrued from the CR this year, which has to be spent by the end of 2025, and Chris goes on to say that exploration drilling will recommence next year. I think they're taking the right course of action to conserve cash as far as possible for the time being, not least because until the spodumene price increases even outstanding assay results will largely fall on deaf ears amongst investors. If possible we'd all much prefer no further CR until there's a marked improvement in our SP.